Weekly Anesthesiology Research Analysis
This week’s anesthesiology literature emphasized clinically actionable, patient-centered evidence across airway management, hemodynamic optimization, and pediatric safety. A large multicenter randomized trial supported video laryngoscopy as the preferred first-line approach for routine operating-room intubation, while a randomized trial found that routine pre-induction crystalloid boluses did not prevent post-induction hypotension. A pediatric dose-response trial established an estimated nalmefe
Summary
This week’s anesthesiology literature emphasized clinically actionable, patient-centered evidence across airway management, hemodynamic optimization, and pediatric safety. A large multicenter randomized trial supported video laryngoscopy as the preferred first-line approach for routine operating-room intubation, while a randomized trial found that routine pre-induction crystalloid boluses did not prevent post-induction hypotension. A pediatric dose-response trial established an estimated nalmefene ED50 for preventing sufentanil-induced cough. Across the week, several studies also showed that improved physiologic surrogate measures do not necessarily translate into better postoperative outcomes, reinforcing the need for individualized, outcome-focused practice.
Selected Articles
1. Conventional vs Video-Assisted Laryngoscopy for Perioperative Endotracheal Intubations: A Randomized Clinical Trial.
In the multicenter COVALENT randomized trial, first-pass success was 78.2% with direct laryngoscopy, 82.9% with Macintosh video laryngoscopy, and 87.6% with hyperangulated video laryngoscopy. Both video laryngoscopy approaches were superior to direct laryngoscopy, with the greatest success observed for hyperangulated devices.
Impact: This large, pragmatic multicenter randomized trial directly addresses a common airway-management decision and provides strong evidence favoring video laryngoscopy for routine operating-room intubation.
Clinical Implications: Video laryngoscopy should be considered the default first-line technique for routine operating-room intubation, while maintaining direct-laryngoscopy competency and selecting blade geometry according to anatomy, expertise, and available equipment.
Key Findings
- First-pass success was 78.2% with direct laryngoscopy, 82.9% with Macintosh video laryngoscopy, and 87.6% with hyperangulated video laryngoscopy.
- Both video laryngoscopy techniques were statistically superior to direct laryngoscopy.
- Video laryngoscopy achieved faster positive capnography after failed first attempts, and hyperangulated devices had fewer reported lip or dental injuries and blood on the blade.
2. Effect of Pre-operative Intravenous Crystalloid Bolus on Post-Induction Blood Pressure - a randomized blinded intervention trial.
In a two-center randomized blinded trial of 504 high-risk adults undergoing major non-cardiac surgery, a crystalloid bolus given within approximately 60 minutes before induction did not reduce the time-weighted mean arterial pressure below 65 mmHg during the first 20 minutes after induction. The findings challenge routine pre-induction fluid loading as a hypotension-prevention strategy.
Impact: This clinically relevant negative randomized trial overturns a common empiric practice and supports individualized hemodynamic management rather than routine fluid administration before induction.
Clinical Implications: Routine pre-induction crystalloid boluses should not be assumed to prevent post-induction hypotension. Clinicians should use individualized volume assessment, maintain vasopressor readiness, and treat hypotension according to the underlying mechanism.
Key Findings
- The analysis included 504 patients: 247 received preoperative crystalloid and 257 received standard care.
- The time-weighted average of mean arterial pressure below 65 mmHg did not differ significantly between groups.
- A crystalloid bolus within 60 minutes before induction did not prevent post-induction hypotension.
3. Median effective dose of intravenous nalmefene for preventing sufentanil-induced cough in children aged 1-6 years: a prospective randomized controlled trial.
This prospective randomized, double-blind, placebo-controlled dose-ranging trial included 249 children aged 1–6 years. Sufentanil-induced cough decreased from 45.9% with saline to 11.3% with nalmefene 0.1 μg/kg, and the estimated nalmefene ED50 was 0.064 μg/kg without apparent loss of hemodynamic stability or postoperative analgesia.
Impact: The study provides an age-specific, prospectively registered dose reference for preventing a potentially hazardous opioid-related airway response in young children.
Clinical Implications: Nalmefene near the estimated ED50 may be considered for selected children aged 1–6 years receiving sufentanil, with monitoring for opioid-antagonist effects and confirmation in broader surgical and respiratory-risk populations.
Key Findings
- The trial enrolled 249 children aged 1–6 years and was prospectively registered.
- Sufentanil-induced cough decreased from 45.9% with saline to 11.3% with nalmefene 0.1 μg/kg.
- The estimated nalmefene ED50 was 0.064 μg/kg, with preserved hemodynamic stability and postoperative analgesia.